drugset
drugset / Trial / NCT05327491

A Study in Healthy Volunteers to Compare the Pharmacokinetics of Sotorasib Administered as 1 or 2 Tablets

NCT05327491 ↗

Phase 1 Completed 146 enrolled Amgen
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of the study is to compare the pharmacokinetics (PK) of sotorasib administered orally as 1 tablet under fasted conditions to sotorasib administered orally as 2 tablets under fasted conditions.

Timeline

Start
2022-03-21
Primary completion
2022-07-17
Completion
2022-07-17

Drugs

EvaluationDrugModalityDoseRoute
Subject Sotorasib Small molecule — Oral

Indications

No indication recorded.